Different Modalities Interventions Post Supracondylar Humeral Fracture in Pediatrics

Launched by CAIRO UNIVERSITY · Jan 14, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of two different treatment methods, Low-Level Laser Therapy (LLLT) and Pulsed Electromagnetic Field Therapy (PEMFT), on children who have suffered from a specific type of arm fracture called a supracondylar humeral fracture. The goal is to see how these treatments can help improve elbow movement, reduce pain, strengthen muscles in the arm, and enhance hand function after surgery for this type of fracture.

To participate in the trial, children must be between 6 and 10 years old and have a type II or III supracondylar humeral fracture that needs surgical treatment. They should be healthy enough to follow instructions and should not have any other serious medical issues, like infections or neurological problems. If selected, participants will start the study shortly after their splint is removed and will receive one of the two treatment methods to help them recover better. This trial aims to find out which of the two treatments is more effective in helping young patients heal and regain full use of their arm.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age ranges from 6 to 10 years of both genders.
• • 2. All subjects have unilateral extension type II and III supracondylar humeral fracture requiring closed reduction and percutaneous pinning (CRPP).
• • 3. The study will be start immediately after removal the splint.
• • 4. Children clinically and medically stable.
• • 5. Children able to follow verbal commands.
• • 6. Children sample will represent those children who enrolled in schools and other not yet.
• • -
• Exclusion Criteria:
• • The patients will be excluded if they have one of the following criteria;
• • 1. Previous soft tissue injury at the same affected side of fracture.
• • 2. Presence of associated fractures on the ipsilateral or contralateral upper limb.
• • 3. Active infection near the fracture site.
• • 4. Children with congenital or acquired skeletal deformities in the upper limbs.
• • 5. Children with neurological deficits such as convulsions, involuntary movements, receiving muscle relaxants.
• • -